ArticlePloS one2024

The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors.

Eun-Jeong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.